Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States
Quan Qiu Wang, David C. Kaelber, Rong Xu, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 1, pp. 30-39
Open Access | Times Cited: 594

Showing 1-25 of 594 citing articles:

Increased risk of COVID‐19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States
QuanQiu Wang, Rong Xu, Nora D. Volkow
World Psychiatry (2020) Vol. 20, Iss. 1, pp. 124-130
Open Access | Times Cited: 570
COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State
James M. Tesoriero, Carol-Ann Swain, Jennifer L. Pierce, et al.
JAMA Network Open (2021) Vol. 4, Iss. 2, pp. e2037069-e2037069
Open Access | Times Cited: 360
Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis
Benedetta Vai, Mario Gennaro Mazza, Claudia Colli, et al.
The Lancet Psychiatry (2021) Vol. 8, Iss. 9, pp. 797-812
Open Access | Times Cited: 276
COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US
QuanQiu Wang, Pamela B. Davis, Mark E. Gurney, et al.
Alzheimer s & Dementia (2021) Vol. 17, Iss. 8, pp. 1297-1306
Open Access | Times Cited: 235
Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study
Nicolas Hoertel, Marina Sánchez‐Rico, Raphaël Vernet, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 9, pp. 5199-5212
Open Access | Times Cited: 235
Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries
Guillaume Fond, Katlyn Nemani, Damien Etchecopar‐Etchart, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 11, pp. 1208-1208
Open Access | Times Cited: 201
Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death
Felicia Ceban, Danica Nogo, Isabelle P. Carvalho, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 10, pp. 1079-1079
Open Access | Times Cited: 181
COVID-19 vaccination for people with severe mental illness: why, what, and how?
Victor Mazereel, Kristof Van Assche, Johan Detraux, et al.
The Lancet Psychiatry (2021) Vol. 8, Iss. 5, pp. 444-450
Open Access | Times Cited: 148
Neuropsychiatric Complications of COVID-19
Zev M. Nakamura, Rebekah P. Nash, Sarah L. Laughon, et al.
Current Psychiatry Reports (2021) Vol. 23, Iss. 5
Open Access | Times Cited: 142
Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021
Lindsey Wang, QuanQiu Wang, Pamela B. Davis, et al.
World Psychiatry (2021) Vol. 21, Iss. 1, pp. 124-132
Open Access | Times Cited: 126
COVID-19 rebound after Paxlovid and Molnupiravir during January-June 2022
Lindsey Wang, Nathan A. Berger, Pamela B. Davis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 119
Effects of the COVID-19 pandemic and lockdown on alcohol use disorders and complications
Pratima Murthy, Venkata Lakshmi Narasimha
Current Opinion in Psychiatry (2021) Vol. 34, Iss. 4, pp. 376-385
Open Access | Times Cited: 118
Racial/Ethnic Disparities in Unintentional Fatal and Nonfatal Emergency Medical Services–Attended Opioid Overdoses During the COVID-19 Pandemic in Philadelphia
Utsha G. Khatri, Lia Pizzicato, Kendra Viner, et al.
JAMA Network Open (2021) Vol. 4, Iss. 1, pp. e2034878-e2034878
Open Access | Times Cited: 109
Changes in alcohol use during theCOVID‐19 pandemic in Europe: A meta‐analysis of observational studies
Carolin Kilian, Amy O’Donnell, N V Potapova, et al.
Drug and Alcohol Review (2022) Vol. 41, Iss. 4, pp. 918-931
Open Access | Times Cited: 94
The impacts of COVID-19 pandemic on service delivery and treatment outcomes in people living with HIV: a systematic review
SeyedAhmad SeyedAlinaghi, Pegah Mirzapour, Zahra Pashaei, et al.
AIDS Research and Therapy (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 70
Healthcare on the brink: navigating the challenges of an aging society in the United States
Charles H. Jones, Mikael Dolsten
npj Aging (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 54
Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review
Noa Krawczyk, Adetayo Fawole, Jenny Yang, et al.
Addiction Science & Clinical Practice (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 79
When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities
QuanQiu Wang, Nathan A. Berger, Rong Xu
Blood Reviews (2020) Vol. 47, pp. 100775-100775
Open Access | Times Cited: 74
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective
Sarah Halawa, Soni Savai Pullamsetti, Charles R. M. Bangham, et al.
Nature Reviews Cardiology (2021) Vol. 19, Iss. 5, pp. 314-331
Open Access | Times Cited: 74
The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data
Sameer Imtiaz, Frishta Nafeh, Cayley Russell, et al.
Substance Abuse Treatment Prevention and Policy (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 72
Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada
Paul J. Joudrey, Zoe Adams, Paxton Bach, et al.
JAMA Network Open (2021) Vol. 4, Iss. 7, pp. e2118223-e2118223
Open Access | Times Cited: 68
Risks and Benefits of Cannabis and Cannabinoids in Psychiatry
Kevin P. Hill, Mark S. Gold, Charles B. Nemeroff, et al.
American Journal of Psychiatry (2021) Vol. 179, Iss. 2, pp. 98-109
Closed Access | Times Cited: 68
COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research
Lindsey Wang, David C. Kaelber, Rong Xu, et al.
Blood Reviews (2022) Vol. 54, pp. 100931-100931
Open Access | Times Cited: 64
A rapid diagnosis of SARS-CoV-2 using DNA hydrogel formation on microfluidic pores
Hwang-soo Kim, Naseem Abbas, Sehyun Shin
Biosensors and Bioelectronics (2021) Vol. 177, pp. 113005-113005
Open Access | Times Cited: 61
Sex and Gender Differences in Testing, Hospital Admission, Clinical Presentation, and Drivers of Severe Outcomes From COVID-19
Eileen P. Scully, Grant Schumock, Martina Fu, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 9
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top